Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
Pierre‐Régis Burgel, I. Durieu, R. Chiron, Laurent Mély, Anne Prévötat, M. Murris‐Espin, Michele Porzio, Michel Abély, Philippe Reix, Christophe Marguet, Julie Macey, Isabelle Sermet‐Gaudelus, Harriet Corvol, S. Bui, Tiphaine Biouhee, D. Hubert, À. Munck, Lydie Lemonnier, Clémence Dehillotte, Jennifer Da Silva, Jean-Louis Paillasseur, Clémence Martin
Topics & Concepts
IvacaftorMedicineCystic fibrosisDiscontinuationInternal medicineCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesTracheal and airway disorders